{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T13:23:21Z","timestamp":1740144201566,"version":"3.37.3"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,3,19]],"date-time":"2021-03-19T00:00:00Z","timestamp":1616112000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,19]],"date-time":"2021-03-19T00:00:00Z","timestamp":1616112000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1007\/s12282-021-01236-x","type":"journal-article","created":{"date-parts":[[2021,3,19]],"date-time":"2021-03-19T13:03:45Z","timestamp":1616159025000},"page":"1016-1022","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical effect of the pathological axillary assessment method in breast cancer without clinical nodal metastasis"],"prefix":"10.1007","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1623-869X","authenticated-orcid":false,"given":"Shinsuke","family":"Sasada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norio","family":"Masumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Emi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Kadoya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Arihiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morihito","family":"Okada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,3,19]]},"reference":[{"key":"1236_CR1","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/1097-0142(19890101)63:1<181::AID-CNCR2820630129>3.0.CO;2-H","volume":"63","author":"CL Carter","year":"1989","unstructured":"Carter CL, Allen C, Henson DE. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer. 1989;63:181\u20137.","journal-title":"Cancer"},{"key":"1236_CR2","unstructured":"NCCN Clinical Practice Guidelines in Oncology Breast Cancer. 2018. Available. Accessed 09 June 2018."},{"key":"1236_CR3","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/s1470-2045(10)70207-2","volume":"11","author":"DN Krag","year":"2010","unstructured":"Krag DN, Anderson SJ, Julian TB, Brown AM, Harlow SP, Costantino JP, et al. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol. 2010;11:927\u201333. https:\/\/doi.org\/10.1016\/s1470-2045(10)70207-2.","journal-title":"Lancet Oncol"},{"key":"1236_CR4","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3322\/caac.21388","volume":"67","author":"MB Amin","year":"2017","unstructured":"Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK, et al. The Eighth Edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more \u201cpersonalized\u201d approach to cancer staging. CA Cancer J Clin. 2017;67:93\u20139. https:\/\/doi.org\/10.3322\/caac.21388.","journal-title":"CA Cancer J Clin"},{"key":"1236_CR5","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1093\/jnci\/djq008","volume":"102","author":"M de Boer","year":"2010","unstructured":"de Boer M, van Dijck JA, Bult P, Borm GF, Tjan-Heijnen VC. Breast cancer prognosis and occult lymph node metastases, isolated tumor cells, and micrometastases. J Natl Cancer Inst. 2010;102:410\u201325. https:\/\/doi.org\/10.1093\/jnci\/djq008.","journal-title":"J Natl Cancer Inst"},{"key":"1236_CR6","doi-asserted-by":"publisher","first-page":"3378","DOI":"10.1245\/s10434-007-9513-6","volume":"14","author":"SL Chen","year":"2007","unstructured":"Chen SL, Hoehne FM, Giuliano AE. The prognostic significance of micrometastases in breast cancer: a SEER population-based analysis. Ann Surg Oncol. 2007;14:3378\u201384. https:\/\/doi.org\/10.1245\/s10434-007-9513-6.","journal-title":"Ann Surg Oncol"},{"key":"1236_CR7","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.breast.2014.04.004","volume":"23","author":"G Houvenaeghel","year":"2014","unstructured":"Houvenaeghel G, Classe JM, Garbay JR, Giard S, Cohen M, Faure C, et al. Prognostic value of isolated tumor cells and micrometastases of lymph nodes in early-stage breast cancer: a French sentinel node multicenter cohort study. Breast. 2014;23:561\u20136. https:\/\/doi.org\/10.1016\/j.breast.2014.04.004.","journal-title":"Breast"},{"key":"1236_CR8","doi-asserted-by":"publisher","first-page":"4679","DOI":"10.1200\/jco.2008.19.0686","volume":"27","author":"NM Hansen","year":"2009","unstructured":"Hansen NM, Grube B, Ye X, Turner RR, Brenner RJ, Sim MS, et al. Impact of micrometastases in the sentinel node of patients with invasive breast cancer. J Clin Oncol. 2009;27:4679\u201384. https:\/\/doi.org\/10.1200\/jco.2008.19.0686.","journal-title":"J Clin Oncol"},{"key":"1236_CR9","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s10549-016-4015-5","volume":"161","author":"J Iqbal","year":"2017","unstructured":"Iqbal J, Ginsburg O, Giannakeas V, Rochon PA, Semple JL, Narod SA. The impact of nodal micrometastasis on mortality among women with early-stage breast cancer. Breast Cancer Res Treat. 2017;161:103\u201315. https:\/\/doi.org\/10.1007\/s10549-016-4015-5.","journal-title":"Breast Cancer Res Treat"},{"key":"1236_CR10","doi-asserted-by":"publisher","first-page":"2868","DOI":"10.1200\/jco.2009.24.5001","volume":"28","author":"Y Andersson","year":"2010","unstructured":"Andersson Y, Frisell J, Sylvan M, de Boniface J, Bergkvist L. Breast cancer survival in relation to the metastatic tumor burden in axillary lymph nodes. J Clin Oncol. 2010;28:2868\u201373. https:\/\/doi.org\/10.1200\/jco.2009.24.5001.","journal-title":"J Clin Oncol"},{"key":"1236_CR11","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/s1470-2045(18)30380-2","volume":"19","author":"V Galimberti","year":"2018","unstructured":"Galimberti V, Cole BF, Viale G, Veronesi P, Vicini E, Intra M, et al. Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial. Lancet Oncol. 2018;19:1385\u201393. https:\/\/doi.org\/10.1016\/s1470-2045(18)30380-2.","journal-title":"Lancet Oncol"},{"key":"1236_CR12","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/s1470-2045(13)70035-4","volume":"14","author":"V Galimberti","year":"2013","unstructured":"Galimberti V, Cole BF, Zurrida S, Viale G, Luini A, Veronesi P, et al. Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial. Lancet Oncol. 2013;14:297\u2013305. https:\/\/doi.org\/10.1016\/s1470-2045(13)70035-4.","journal-title":"Lancet Oncol"},{"key":"1236_CR13","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1245\/s10434-012-2569-y","volume":"20","author":"M Sola","year":"2013","unstructured":"Sola M, Alberro JA, Fraile M, Santesteban P, Ramos M, Fabregas R, et al. Complete axillary lymph node dissection versus clinical follow-up in breast cancer patients with sentinel node micrometastasis: final results from the multicenter clinical trial AATRM 048\/13\/2000. Ann Surg Oncol. 2013;20:120\u20137. https:\/\/doi.org\/10.1245\/s10434-012-2569-y.","journal-title":"Ann Surg Oncol"},{"key":"1236_CR14","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/s1470-2045(07)70278-4","volume":"8","author":"DN Krag","year":"2007","unstructured":"Krag DN, Anderson SJ, Julian TB, Brown AM, Harlow SP, Ashikaga T, et al. Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial. Lancet Oncol. 2007;8:881\u20138. https:\/\/doi.org\/10.1016\/s1470-2045(07)70278-4.","journal-title":"Lancet Oncol"},{"key":"1236_CR15","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/S1470-2045(06)70947-0","volume":"7","author":"U Veronesi","year":"2006","unstructured":"Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V, et al. Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomised controlled study. Lancet Oncol. 2006;7:983\u201390. https:\/\/doi.org\/10.1016\/S1470-2045(06)70947-0.","journal-title":"Lancet Oncol"},{"key":"1236_CR16","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/cncr.21568","volume":"106","author":"T Kim","year":"2006","unstructured":"Kim T, Giuliano AE, Lyman GH. Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: a metaanalysis. Cancer. 2006;106:4\u201316. https:\/\/doi.org\/10.1002\/cncr.21568.","journal-title":"Cancer"},{"key":"1236_CR17","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1056\/NEJMoa1008108","volume":"364","author":"DL Weaver","year":"2011","unstructured":"Weaver DL, Ashikaga T, Krag DN, Skelly JM, Anderson SJ, Harlow SP, et al. Effect of occult metastases on survival in node-negative breast cancer. N Engl J Med. 2011;364:412\u201321. https:\/\/doi.org\/10.1056\/NEJMoa1008108.","journal-title":"N Engl J Med"},{"key":"1236_CR18","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1097\/PAS.0b013e3181b274e7","volume":"33","author":"DL Weaver","year":"2009","unstructured":"Weaver DL, Le UP, Dupuis SL, Weaver KA, Harlow SP, Ashikaga T, et al. Metastasis detection in sentinel lymph nodes: comparison of a limited widely spaced (NSABP protocol B-32) and a comprehensive narrowly spaced paraffin block sectioning strategy. Am J Surg Pathol. 2009;33:1583\u20139. https:\/\/doi.org\/10.1097\/PAS.0b013e3181b274e7.","journal-title":"Am J Surg Pathol"},{"key":"1236_CR19","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1097\/00000478-200203000-00013","volume":"26","author":"MA Yared","year":"2002","unstructured":"Yared MA, Middleton LP, Smith TL, Kim HW, Ross MI, Hunt KK, et al. Recommendations for sentinel lymph node processing in breast cancer. Am J Surg Pathol. 2002;26:377\u201382.","journal-title":"Am J Surg Pathol"},{"key":"1236_CR20","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y. Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics. Bone Marrow Transplant. 2013;48:452\u20138. https:\/\/doi.org\/10.1038\/bmt.2012.244.","journal-title":"Bone Marrow Transplant"},{"key":"1236_CR21","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1002\/1097-0142(20001215)89:12<2527::AID-CNCR3>3.0.CO;2-6","volume":"89","author":"G Farshid","year":"2000","unstructured":"Farshid G, Pradhan M, Kollias J, Gill PG. Computer simulations of lymph node metastasis for optimizing the pathologic examination of sentinel lymph nodes in patients with breast carcinoma. Cancer. 2000;89:2527\u201337.","journal-title":"Cancer"},{"key":"1236_CR22","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1002\/(sici)1096-9098(199812)69:4<212::aid-jso4>3.0.co;2-v","volume":"69","author":"JS Meyer","year":"1998","unstructured":"Meyer JS. Sentinel lymph node biopsy: strategies for pathologic examination of the specimen. J Surg Oncol. 1998;69:212\u20138. https:\/\/doi.org\/10.1002\/(sici)1096-9098(199812)69:4%3c212::aid-jso4%3e3.0.co;2-v.","journal-title":"J Surg Oncol"},{"key":"1236_CR23","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1093\/annonc\/mdm271","volume":"18","author":"A Goldhirsch","year":"2007","unstructured":"Goldhirsch A, Wood WC, Gelber RD, Coates AS, Thurlimann B, Senn HJ. Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007. Ann Oncol. 2007;18:1133\u201344. https:\/\/doi.org\/10.1093\/annonc\/mdm271.","journal-title":"Ann Oncol"},{"key":"1236_CR24","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1093\/annonc\/mdr304","volume":"22","author":"A Goldhirsch","year":"2011","unstructured":"Goldhirsch A, Wood WC, Coates AS, Gelber RD, Th\u00fcrlimann B, Senn HJ, et al. Strategies for subtypes-dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Ann Oncol. 2011;22:1736\u201347. https:\/\/doi.org\/10.1093\/annonc\/mdr304.","journal-title":"Ann Oncol"},{"key":"1236_CR25","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12957-019-1585-9","volume":"17","author":"H Shigematsu","year":"2019","unstructured":"Shigematsu H, Nishina M, Yasui D, Hirata T, Ozaki S. Minimal prognostic significance of sentinel lymph node metastasis in patients with cT1-2 and cN0 breast cancer. World J Surg Oncol. 2019;17:41. https:\/\/doi.org\/10.1186\/s12957-019-1585-9.","journal-title":"World J Surg Oncol"},{"key":"1236_CR26","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1097\/SLA.0000000000001549","volume":"264","author":"NS Tucker","year":"2016","unstructured":"Tucker NS, Cyr AE, Ademuyiwa FO, Tabchy A, George K, Sharma PK, et al. Axillary ultrasound accurately excludes clinically significant lymph node disease in patients with early stage breast cancer. Ann Surg. 2016;264:1098\u2013102. https:\/\/doi.org\/10.1097\/SLA.0000000000001549.","journal-title":"Ann Surg"}],"container-title":["Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12282-021-01236-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12282-021-01236-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12282-021-01236-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T15:55:23Z","timestamp":1628610923000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12282-021-01236-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,19]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["1236"],"URL":"https:\/\/doi.org\/10.1007\/s12282-021-01236-x","relation":{},"ISSN":["1340-6868","1880-4233"],"issn-type":[{"type":"print","value":"1340-6868"},{"type":"electronic","value":"1880-4233"}],"subject":[],"published":{"date-parts":[[2021,3,19]]},"assertion":[{"value":"4 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the Institutional Review Board. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For this type of study formal consent is not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}